These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8485654

  • 1. Fludarabine in the treatment of lymphoproliferative malignancies.
    Feldman EJ, Keating MJ.
    Cancer Invest; 1993; 11(3):314-8. PubMed ID: 8485654
    [No Abstract] [Full Text] [Related]

  • 2. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S.
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM, Narasihman P, Venkatesh L, Cawley M, Kaplan B.
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fludarabine phosphate--looking forward.
    Cheson BD.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR, Perry CM.
    Drugs; 2007 Oct; 67(11):1633-55. PubMed ID: 17661532
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for Pneumocystis jirovecii pneumonia in patients with lymphoproliferative disorders.
    Obeid KM, Aguilar J, Szpunar S, Sharma M, del Busto R, Al-Katib A, Johnson LB.
    Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):66-9. PubMed ID: 22000698
    [Abstract] [Full Text] [Related]

  • 12. Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience.
    O'Brien ME, Matutes E, Cunningham D, Hill M, Emmett E, Ellis PA, Milan S, Hickish T, Mercieca J, Catovsky D.
    Leuk Lymphoma; 1994 Feb; 14 Suppl 2():17-23. PubMed ID: 7881347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
    Pott-Hoeck C, Hiddemann W.
    Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
    [Abstract] [Full Text] [Related]

  • 16. Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
    Whelan JS, Davis CL, Rule S, Ranson M, Smith OP, Mehta AB, Catovsky D, Rohatiner AZ, Lister TA.
    Br J Cancer; 1991 Jul; 64(1):120-3. PubMed ID: 1713049
    [Abstract] [Full Text] [Related]

  • 17. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE, Matutes E, Catovsky D.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [Abstract] [Full Text] [Related]

  • 18. Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes.
    Helman DL, Byrd JC, Ales NC, Shorr AF.
    Chest; 2002 Sep; 122(3):785-90. PubMed ID: 12226014
    [Abstract] [Full Text] [Related]

  • 19. Fludarabine approved for use in chronic lymphocytic leukemia.
    Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
    [No Abstract] [Full Text] [Related]

  • 20. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep 18; 34(879):89-90. PubMed ID: 1355592
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.